Biotechnology News

April 26, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced its results for the first quarter ended March 31, 2012. Net sales of $143.1 million represent an increase of 3% over the first quarter...

April 26, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced that Ron Squarer has been appointed Chief Executive Officer, effective immediately. Mr. Squarer has also been named to the Array Board of Directors. Mr. Squarer...

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Reports First Quarter 2012 Financial Results and Provides Update on Launch of KALYDECOTM

April 26, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its first quarter ended March...

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the first quarter ending March 31, 2012 on Thursday, May 3, 2012,...

April 26, 2012

WASHINGTON--(BUSINESS WIRE)--BIO submitted testimony to the House Ways and Means subcommittee on the importance of tax extenders for advanced biofuels

April 26, 2012

ATLANTA--(BUSINESS WIRE)--Dodge Communications, an integrated communications agency, has joined the Metro Atlanta Chamber (MAC) Board of Advisors and the BioScience and Health IT Leadership Council.

April 26, 2012

MISGAV, Israel and SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

April 26, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced findings from several studies of TYSABRI® (natalizumab) evaluating its long-term safety and efficacy in the treatment of...

April 26, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--The Coalition to Cure Prostate Cancer (CCPC) is a new Canadian Foundation — formed in the last year — committed to accelerating advanced research with the ultimate goal of ending death and suffering...

April 26, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced findings from several studies of TYSABRI® (natalizumab) evaluating its long-term safety and efficacy in the treatment of...

April 26, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Entrepreneurs with startups or business plans serving the baby boomer market are invited to apply to the 9th annual Silicon Valley Boomer Venture Summit and Business Plan Competition at SCU June 20.

April 26, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen announces new data suggesting expanded therapeutic potential for lead program in both metabolic disorders and cardiovascular disease. Findings published today in the journal Cell.

April 26, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Patient adherence teams for many drug brands are boosting spending this year on new digital tools in a bid to better reach patients and drive higher patient adherence.

April 26, 2012

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the Obama Administration's new National Bioeconomy Blueprint issued today: “BIO applauds President...

April 26, 2012

ATLANTA--(BUSINESS WIRE)--Insights into the effects of Neupro® (rotigotine transdermal system) on common non-motor symptoms of Parkinson’s disease (PD) were presented today at the 64th AAN Annual Meeting in New Orleans, LA. A post-hoc analysis of...

April 26, 2012

RAVENSBURG, Germany--(BUSINESS WIRE)--As part of its business growth strategy Vetter has announced that a triple-digit million euro syndicated loan has been arranged with a consortium of renowned banks at the end of march.

April 26, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA (OSE:DIAG) The new date for the Annual General Meeting is June 26 2012 at 13.00 Norwegian time. Notice of the Annual General Meeting will be issued in a separate notice. About DiaGenic...

April 26, 2012

--(BUSINESS WIRE)--LES (USA & Canada) will host top execs and thought leaders May 15-17 in Boston to examine challenges facing the life science industry and strategies for resolving the innovation gap.

April 26, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) announced today that midday yesterday, the FDA notified the Company that the FDA Advisory Committee meeting previously scheduled for May 31 to review RG1068 for pancreatic...

April 26, 2012

WASHINGTON--(BUSINESS WIRE)--BIO thanks Senators Lugar, Conrad and nine other cosponsors of an amendment to the Farm Bill that would ensure funds for farm energy programs at USDA

April 26, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage (STO:BIOTA): First quarter 2012 · Group net sales increased by 12 percent to 119.6 MSEK (107.2). At comparable exchange rates sales increased by 8 percent. · The operating result amounted...

April 26, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Micromedics Inc., a subsidiary of Nordson Corporation (NASDAQ: NDSN), recently concluded a clinical study of the Artiste® Assisted Injection System.

April 26, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, has been named one of the “Best Places to Work in New...

April 26, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced that it will webcast today’s corporate presentation at 9:15 a.m. PDT, after the formal portion of...

April 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Senomyx, Inc. (NASDAQ:SNMX), will release its financial results for the first quarter ended March 31, 2012 on Thursday, May 3, 2012 before the opening of the U.S. financial markets. The Company will also host a...

April 26, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company, announced that the company will host a conference call and webcast on May 7, 2012 at 4:30 p.m. Eastern time to discuss its first...

April 26, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients...

April 26, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the first quarter of 2012 on Thursday, May 3, 2012 at 7:00 a.m. eastern time. The Company will hold a conference call at 9:...

April 26, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today it has exercised its option and completed the purchase of SIGMA International General Medical Apparatus, LLC., a privately held company based in Medina, New...

April 26, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced its support of the North Atlantic Treaty Organization (NATO) Emerging Security Challenges Division (ESCD) in hosting a biopreparedness workshop entitled “A Bio...

April 26, 2012

SEATTLE--(BUSINESS WIRE)--Cadence Biomedical, a provider of medical devices that help people with severe disabilities walk, announced the closing of an oversubscribed $1.1 million Series A2 financing led by HealthTech Capital. Other investors...

April 26, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2012 financial results after the close of the market on Thursday, May 3, 2012. The company plans to hold a...

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem to present at Deutsche Bank 37th Annual Health Care Conference on May 9, 2012.

April 26, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced interim data from a prospective, open label survey study evaluating spasticity in patients with relapsing-remitting multiple sclerosis (RRMS) who...

April 26, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced Dallas-based AHI Facility Services, Inc. as a regional strategic customer in the contract...

April 26, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: reported record fiscal 2012 second quarter and six months net sales of $47.4 million and $...

April 26, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Based on the success of the collaboration up, Novartis has exercised its second option to extend its oncology discovery research collaboration with Zalicus for an additional contract year

April 26, 2012

CAMBRIDGE, Mass. & SUMMIT, N.J.--(BUSINESS WIRE)--Epizyme and Celgene announced a partnership to discover, develop and commercialize personalized therapeutics for patients with genetically-defined cancers. Epizyme will receive $90 million up...

April 26, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is reporting record revenue and profits for first quarter of 2012.

April 26, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported Non-GAAP net product sales of $1,245 million for the first quarter of 2012, a 17 percent increase from the same period in 2011. Non-GAAP net income for the first quarter...

April 26, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced financial results for the three months ended March 31, 2012. For the first quarter ended March 31, 2012, the Company reported revenue of $59.5 million,...

April 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter ended March 31, 2012.

April 26, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today reported first-quarter 2012 financial results, including revenue from its first commercial product, JakafiTM (ruxolitinib), which was approved by the US Food & Drug...

April 26, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Confirms Takeda’s Receipt of Complete Response Letter from the FDA for Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that financial results for the company's first quarter ended March 31, 2012 will be released before the market opens on Thursday, May 3, 2012. The AVEO...

April 26, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Steady growth and expansion at our partner companies, despite the fragile state of the macro-economy, continues to validate Safeguard’s strategic focus.